CLINICAL_TRIALS
withdrawal
· 2016-09-14
Clinical Trial Update: An Open-Label Extension to Protocol 09-1, Efficacy and Safety Study of the EndoBarrier® Gastrointestinal Liner System [NA]
Summary
An open-label extension study for the EndoBarrier Gastrointestinal Liner System has been withdrawn from the trial.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morphic Medical Inc. | Conditions: Type 2 Diabetes | NA | Status: WITHDRAWN